相关实验视频
Updated: Jun 23, 2025
04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
289
基于系统生物学的萨尔科佩尼亚的新药标和分子机制
Atakan Burak Ceyhan1, Mehmet Ozcan2, Woonghee Kim3
1Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London SE1 9RT, UK.
概括
这项研究确定了关键的基因和用于治疗老年人中影响老年人的疾病 - - 麻症的重定向药物. MG-132和托格利塔在治疗与年龄相关的肌肉损失方面表现有前途.
科学领域:
- 老年学是指老年学的学科.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 标志着与年龄相关的肌肉损失的萨尔科佩尼亚,带来了重大的公共卫生挑战,增加了老年人的残疾和死亡风险.
- 了解萨科佩尼亚背后的复杂分子机制对于开发有效的治疗策略至关重要.
研究的目的:
- 通过系统生物学来研究萨尔科佩尼亚的分子病原性.
- 为了确定新的治疗点和潜在的药物候选人,用于治疗肉症.
主要方法:
- 分析了来自肉和健康个体的RNA-seq数据.
- 差异性基因表达的应用,基因组丰富,共同表达网络和网络拓分析.
- 使用药物重新定位策略来识别潜在的萨科佩尼亚治疗现有药物.
主要成果:
- 六个枢纽基因 (PDHX,AGL,SEMA6C,CASQ1,MYORG,CCDC69) 被确定为在肉病原发生过程中的关键基因.
- 一个药物重新定位屏幕确定了几种化合物,包括纤维酸,格利塔,维他法林-a,palbociclib,MG-132和博特佐米布.
- 在C2C12肌肉细胞中的体外验证强调了MG-132和格利塔作为有前途的治疗候选者.
结论:
- 系统生物学和药物重新定位提供了一种强有力的方法来揭开sarcopenia的分子基础.
- 在老年人中,MG-132和托格利塔代表了管理老年人的潜在新疗法选择.
- 这项研究为进一步调查针对与年龄相关的肌肉衰退的药理干预提供了基础.
相关概念视频
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:58Regulated Protein Degradation
2.5K
2.5K